CCL20 and neoplasm: The telomerase reverse transcriptase (TERT)-positive tumor treated with CCL20/IL15-armed oAd that replicated under control of the TERT promoter plus NK showed significantly higher antitumor efficacy than either of the treatments alone and induced tumor-specific cytotoxicity of CTLs.